Barclays raised the firm’s price target on Synovus (SNV) to $67 from $60 and keeps an Overweight rating on the shares as part of a Q2 earnings preview for the mid-cap banks. The firm believes valuations in the group still largely underappreciate an improving operating and regulatory backdrop.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on SNV: